ArticleProceedings of the National Academy of Sciences of the United States of America2021

TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia.

Maike Bensberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.